Clinical Trials Browser

Phase 1 × tozasertib × Tumor-Agnostic × Clear all

NCT02532868 2015-08-26

A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)

Phase 1 Terminated

Neoplasms